2-Oct-2026
Tom's of Maine Introduces Hydroxyapatite Toothpaste to Meet Rising Consumer Demand
PRNewswire (Wed, 23-Sep 9:05 AM ET)
Colgate-Palmolive Declares Regular Quarterly Dividend
Business Wire (Thu, 17-Sep 4:35 PM ET)
PRNewswire (Fri, 4-Sep 7:16 PM ET)
Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference
Business Wire (Thu, 27-Aug 10:10 AM ET)
Colgate-Palmolive Delivers Broad-Based Growth in Q2 2026 Amid Higher Margins and Strong Investment
Market Chameleon (Fri, 31-Jul 3:32 AM ET)
Colgate Announces 2nd Quarter 2026 Results
Business Wire (Fri, 31-Jul 6:55 AM ET)
Colgate-Palmolive Webcasts 2026 Second Quarter Earnings Conference Call July 31, 2026 - 8:30 a.m. ET
Business Wire (Fri, 17-Jul 9:30 AM ET)
Colgate-Palmolive Marks Historic 220th Anniversary as NYSE Highlights Innovation and Milestones
Market Chameleon (Mon, 8-Jun 5:27 AM ET)
Has CL been a good buy before earnings?
Market Chameleon (Wed, 15-Apr 6:13 AM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of October 2, 2026, CL stock price declined to $84.26 with 5,484,050 million shares trading.
CL has a beta of 0.25, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.03 to the broad based SPY ETF.
CL has a market cap of $67.54 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.99 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.04.
In the last 3 years, CL traded as high as $109.30 and as low as $67.62.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
CL has underperformed the market in the last year with a price return of +10.3% while the SPY ETF gained +16.1%. CL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.9% and -3.7%, respectively, while the SPY returned +3.6% and +1.0%, respectively.
CL support price is $83.57 and resistance is $85.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.